Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry
Sign Up to like & getrecommendations! Published in 2019 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.119.086348
Abstract: Efavirenz (more specifically the S-enantiomer) is a cornerstone antiretroviral therapy for treatment of HIV infection. The major primary metabolite is S-8-hydroxyefavirenz, which does not have antiretroviral activity but is neurotoxic. Cytochrome P450 2B6 (CYP2B6) is… read more here.
Keywords: cyp2b6; efavirenz hydroxylation; cyp2b6 variants; efavirenz metabolism ... See more keywords